Korea Bio-Gen Co.Ltd Capital Reinvestment Ratio
Korea Bio-Gen Co.Ltd capital reinvestment ratio. Korea Bio-Gen Co.Ltd (318000) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩1.51 Billion) in capital expenditures (₩40.03 Million). Check Korea Bio-Gen Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Korea Bio-Gen Co.Ltd (2017–2025)
Capital reinvestment ratio of Korea Bio-Gen Co.Ltd from 2017 to 2025. This chart tracks Korea Bio-Gen Co.Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore Korea Bio-Gen Co.Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Korea Bio-Gen Co.Ltd Capital Reinvestment Ratio by Year (2017–2025)
Korea Bio-Gen Co.Ltd capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Korea Bio-Gen Co.Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | ₩7.34 Billion | ₩462.42 Million | ▼ -94.7% |
| 2024 | 1.19x | ₩4.29 Billion | ₩5.12 Billion | ▲ +366.1% |
| 2023 | 0.26x | ₩9.47 Billion | ₩2.42 Billion | ▼ -81.3% |
| 2022 | 1.37x | ₩1.67 Billion | ₩2.29 Billion | ▲ +79.6% |
| 2021 | 0.76x | ₩3.09 Billion | ₩2.36 Billion | ▲ +125.5% |
| 2020 | 0.34x | ₩2.58 Billion | ₩872.46 Million | ▼ -59.4% |
| 2019 | 0.83x | ₩3.05 Billion | ₩2.55 Billion | ▲ +96.7% |
| 2018 | 0.42x | ₩1.98 Billion | ₩840.93 Million | ▼ -24.6% |
| 2017 | 0.56x | ₩1.38 Billion | ₩777.66 Million | — |